<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-L50ZZO7J</identifier><date>2010</date><creator>Oancea, Simona</creator><relation>documents/doc/L/URN_NBN_SI_doc-L50ZZO7J_001.pdf</relation><relation>documents/doc/L/URN_NBN_SI_doc-L50ZZO7J_001.txt</relation><format format_type="type">article</format><format format_type="volume">no. 3</format><format format_type="extent">str. 630-642</format><format format_type="issue">vol. 57</format><identifier identifier_type="ISSN">1318-0207</identifier><identifier identifier_type="COBISSID">261338368</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-L50ZZO7J</identifier><language>eng</language><publisher>Slovensko kemijsko društvo</publisher><source>Acta chimica slovenica</source><rights>BY</rights><subject language_type_id="eng">antibiotic</subject><subject language_type_id="slv">antibiotiki</subject><subject language_type_id="slv">razvoj zdravil</subject><subject language_type_id="slv">tarčna zdravila</subject><title>An overview of conventional and alternative strategies for developing new antibacterial agents</title></Record>